Prolifica (Prevention of Liver Fibrosis and Cancer in Africa)

Richard T D'Aquila

Third Coast Center for AIDS Research

Liver and intrahepatic bile ducts

Pathology

Ramou Njie

Gambia Hepatitis Intervention Study

Liver and intrahepatic bile ducts

Pathology

Dean W Felsher

Prognostic Metabolic Signatures of Cancers Through Mass Spectrometry Imaging

Non-Hodgkin lymphoma Liver and intrahepatic bile ducts Hodgkin lymphoma

Hematology and hematologic malignancies

Frank Gonzalez

Xenobiotic Receptors – Rockville

Liver and intrahepatic bile ducts

Pathology

Robert W. Coombs

Laboratory Center, AIDS Clinical Trials Group (ACTG); LC 2 / 3

Trachea, bronchus and lung Other pharynx Oesophagus Non-Hodgkin lymphoma Nasopharynx Liver and intrahepatic bile ducts Kidney, renal pelvis and ureter Kaposi sarcoma Hodgkin lymphoma Colorectum Cervix uteri

Habtom Ressom

Analysis of Lc-MS Data to Identify Peptide and Glycan Biomarkers for Hepatocellular Carcinoma.

Liver and intrahepatic bile ducts

Pathology

Carol Prives

Properties and Regulation of p53 in Tumor Cells

Liver and intrahepatic bile ducts Leukaemia

Pathology

Maureen Joffe

HIVs Effects on Breast Cancer Treatment and Outcomes in South Africa

Trachea, bronchus and lung Other pharynx Oesophagus Non-Hodgkin lymphoma Nasopharynx Liver and intrahepatic bile ducts Kidney, renal pelvis and ureter Kaposi sarcoma Hodgkin lymphoma Colorectum Cervix uteri Breast

Christian Abnet

The Golestan Cohort Study

Stomach Oesophagus Liver and intrahepatic bile ducts

Pathology